UNSPSC 51131909: Albumin human

This classification denotes a peptide fragment derived from human blood plasma, or that residual portion of blood that is left after removal of blood cells by centrifugation without prior blood coagulation, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZIF514RVZR. European Medicines Agency schedules albumin human in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Indices SUB12026MIG, SUB12761MIG, SUB50207, and SUB62389. As of Q4 2014, ALBUMIN HUMAN remains the US FDA Preferred Term for this commodity.

UNSPSC 51131909 Albumin human is a Commodity code for a blood-derived therapeutic protein that state and local health authorities procure as a critical clinical supply. Albumin is used in hospital emergency departments, trauma centers, burn units, and specialty care settings to restore blood volume and maintain plasma oncotic pressure in acutely ill or injured patients. State and local governments purchase albumin through health department procurement offices, hospital systems, and regional health authorities as part of their inventory of intravenous therapeutics and emergency medical supplies. The product is typically sourced from licensed manufacturers meeting FDA and United States Pharmacopeia standards, and procurement often flows through group purchasing organizations, state health cooperative purchasing vehicles, or direct contracts with pharmaceutical suppliers.

The source provides no recent state or local solicitations tagged to this code. Without posted RFP, RFQ, IFB, or ITB notices identifying issuing bodies, response dates, or geographic distribution of procurement activity, the extent of current market opportunity under UNSPSC 51131909 cannot be characterized from available records.